Drug-concentration dependent sensitivity to lysis by antibody and complement, of adriamycin- or mitomycin-treated murine lymphoma cells
- 1 January 1987
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 9 (2), 191-197
- https://doi.org/10.1016/0192-0561(87)90094-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Enhancement of murine lymphoma cell lysability by CTL and by LAK cells, after treatments with mitomycin C and with adriamycinInternational Journal of Immunopharmacology, 1986
- Monoclonal Antibodies in the Lymphatics: Selective Delivery to Lymph Node Metastases of a Solid TumorScience, 1983
- Augmentation of in vitro cytotoxicity and in vivo tumor-inhibition by combined use of lymphotoxin-containing supernatants and antitumor drugsCancer Letters, 1983
- Relationship between cell-mediated and humoral immune attack on tumor cellsCellular Immunology, 1982
- Genetics, Regulation, and Specificity of Murine Natural Antitumor Antibodies and Natural Killer Cells23JNCI Journal of the National Cancer Institute, 1981
- Lysis of Tumor Cells by Antibody and Complement. I. Lack of Correlation Between Antigen Content and Lytic SusceptibilityJNCI Journal of the National Cancer Institute, 1973
- Immune Mechanisms in HomotransplantationThe Journal of Immunology, 1961
- IMMUNE MECHANISMS IN HOMOTRANSPLANTATION .2. QUANTITATIVE ASSAY OF IMMUNOLOGIC ACTIVITY OF LYMPHOID CELLS STIMULATED BY TUMOR HOMOGRAFTS1961